[EN] INHIBITORS OF CATECHOL O-METHYL TRANSFERASE AND THEIR USE IN THE TREATMENT OF PSYCHOTIC DISORDERS [FR] INHIBITEURS DE CATÉCHOL O-MÉTHYL TRANSFÉRASE ET UTILISATION ASSOCIÉE DANS LE TRAITEMENT DE TROUBLES PSYCHOTIQUES
[EN] INHIBITORS OF CATECHOL O-METHYL TRANSFERASE AND THEIR USE IN THE TREATMENT OF PSYCHOTIC DISORDERS [FR] INHIBITEURS DE CATÉCHOL O-MÉTHYL TRANSFÉRASE ET UTILISATION ASSOCIÉE DANS LE TRAITEMENT DE TROUBLES PSYCHOTIQUES
[EN] INHIBITORS OF CATECHOL O-METHYL TRANSFERASE AND THEIR USE IN THE TREATMENT OF PSYCHOTIC DISORDERS<br/>[FR] INHIBITEURS DE CATÉCHOL O-MÉTHYL TRANSFÉRASE ET UTILISATION ASSOCIÉE DANS LE TRAITEMENT DE TROUBLES PSYCHOTIQUES
申请人:MERCK SHARP & DOHME
公开号:WO2011109254A1
公开(公告)日:2011-09-09
The present invention relates to 4-pyridinone compounds which are inhibitors of catechol O-methyltransferase (COMT), and are useful in the treatment and prevention of neurological and psychiatric disorders and diseases in which COMT enzyme is involved. The present invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which COMT is involved.
INHIBITORS OF CATECHOL O-METHYL TRANSFERASE AND THEIR USE IN THE TREATMENT OF PSYCHOTIC DISORDERS
申请人:Wolkenberg Scott
公开号:US20130084346A1
公开(公告)日:2013-04-04
The present invention relates to 4-pyridinone compounds which are inhibitors of catechol O-methyltransferase (COMT), and are useful in the treatment and prevention of neurological and psychiatric disorders and diseases in which COMT enzyme is involved. The present invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which COMT is involved.
Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders
申请人:Wolkenberg Scott
公开号:US09024032B2
公开(公告)日:2015-05-05
The present invention relates to 4-pyridinone compounds which are inhibitors of catechol O-methyltransferase (COMT), and are useful in the treatment and prevention of neurological and psychiatric disorders and diseases in which COMT enzyme is involved. The present invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which COMT is involved.
COMPOSITION ANHYDRE COSMETIQUEMENT ACCEPTABLE POUR VERNIS A ONGLES
申请人:International Lacquers
公开号:EP3709962B1
公开(公告)日:2022-01-26
COSMETICALLY ACCEPTABLE ANHYDROUS COMPOSITION FOR NAIL VARNISH
申请人:INTERNATIONAL LACQUERS
公开号:US20210186837A1
公开(公告)日:2021-06-24
A cosmetically acceptable anhydrous composition for nail varnish comprising at least one organic solvent, at least one film-forming agent, at least one plasticizer and at least one thixotropic agent, characterized in that it further comprises at least one nitrosamine-inhibiting thixotropic substance.